Altimmune ALT Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's total operating expenses?
- Altimmune (ALT) reported total operating expenses of $24.24M in Q1 2026.
- How has Altimmune's total operating expenses changed year-over-year?
- Altimmune's total operating expenses increased by 11.1% year-over-year, from $21.82M to $24.24M.
- What is the long-term trend for Altimmune's total operating expenses?
- Over 4 years (2021 to 2025), Altimmune's total operating expenses has grown at a -1.7% compound annual growth rate (CAGR), from $101.32M to $94.53M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.